8-K
Current Report
Liminatus Pharma, Inc. Filed Acc 0001104659-26-012016
Material agreement · Unregistered share sale
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
From the SEC's structured data for this filing
Loading tm265593d1_8k.htm…